Neoadjuvant downsizing by internal radiation: A case for preoperative peptide receptor radionuclide therapy in patients with pancreatic neuroendocrine tumors

2012

Clinical Nuclear Medicine , Volume 37 - Issue 1 p. 102- 104

Additional Metadata
Keywords	Endocrine pancreatic tumors, Lu-177-DOTA-octreotate, Neoadjuvant treatment, Neuroendocrine tumors, Peptide receptor radionuclide therapy, Somatostatin receptor targeting
Persistent URL	doi.org/10.1097/RLU.0b013e318238f003, hdl.handle.net/1765/83399
Journal	Clinical Nuclear Medicine
Organisation	Department of Nuclear Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ezziddin, S., Lauschke, H., Schaefers, M., Meyer, C., van Essen, M., Biersack, H.-J., … Ahmadzadehfar, H. (2012). Neoadjuvant downsizing by internal radiation: A case for preoperative peptide receptor radionuclide therapy in patients with pancreatic neuroendocrine tumors. Clinical Nuclear Medicine, 37(1), 102–104. doi:10.1097/RLU.0b013e318238f003

Publication